The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 171, Issue 1, 2013, Pages 101-106

  Seebacher, Veronika ^a   Grimm, Christoph ^a   Reinthaller, Alexander ^a   Heinze, Georg ^a   Tempfer, Clemens ^a   Hefler, Lukas ^a   Polterauer, Stephan ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Albumin; Endometrial cancer; Hypoalbuminemia; Prognosis; Survival

Indexed keywords

ALBUMIN;

AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REFERENCE VALUE;

ALBUMIN; ENDOMETRIAL CANCER; HYPOALBUMINEMIA; PROGNOSIS; SURVIVAL;

AGED; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPOALBUMINEMIA; MIDDLE AGED; PROGNOSIS; SERUM ALBUMIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84887089489     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2013.07.044     Document Type: Article

References (26)

1. M.P. Margarson, and N. Soni Serum albumin: touchstone or totem Anaesthesia 53 1998 789 803
2. P. Goldwasser, and J. Felman Association of serum albumin and mortality risk J Clin Epidemiol 50 1997 693 703
3. T. Horwich, K. Kalantar-Zadeh, R. MacLellan, and G.C. Fonarow Albumin levels predict survival in patients with systolic heart failure Am Heart J 155 2008 883 889
4. V. Menon, T. Greene, and X. Wang C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease Kidney Int 68 2005 766 772
5. F. Pacelli, G. Doglietto, and S. Alfieri Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients Arch Surg 131 1996 641 645
6. R. Al-Shaiba, D.C. McMillan, W.J. Angerson, E. Leen, C.S. McArdle, and P. Horgan The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases Br J Cancer 91 2004 205 207
7. D.J. Brown, R. Milroy, T. Preston, and D.C. McMillan The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer J Clin Pathol 60 2007 705 708
8. A.M. Al Murri, J.M. Bartlett, P.A. Canney, J.C. Doughty, C. Wilson, and D.C. McMillan Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer Br J Cancer 94 2006 227 230
9. D. Parker, C. Bradley, and S.M. Bogle Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer Br J Obstet Gynaecol 101 1994 888 893
10. R. Sharma, J. Hook, M. Kumar, and H. Gabra Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer Eur J Cancer 44 2008 251 256
11. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
12. T. Kurihara, H. Mizunuma, M. Obara, K. Andoh, Y. Ibuki, and T. Nishimura Determination of a normal level of serum CA 125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma Gynecol Oncol 69 1998 192 196
13. M. Schmid, A. Schneitter, S. Hinterberger, J. Seeber, A. Reinthaller, and L. Hefler Association of elevated C-reactive protein levels with an impaired prognosis in patients with surgically treated endometrial cancer Obstet Gynecol 110 2007 1231 1236
14. V. Seebacher, S. Polterauer, and C. Grimm The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial Br J Cancer 102 2010 952 956
15. W.T. Creasman, F. Odicino, and P. Maisonneuve Carcinoma of the corpus uteri. FIGO 6th annual report on the results of treatment in gynecologic cancer Int J Gynaecol Obstet 95 Suppl. 1 2006 105 143
16. P.G. Hill The measurement of albumin in serum and plasma Ann Clin Biochem 22 1985 565 578
17. P. Royston, and W. Sauerbrei Multivariable model-building - a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables 2008 John Wiley & Sons Ltd. Chichester
18. M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 1996 343 346
19. W.A. Knaus, D.P. Wagner, and E.A. Draper The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults Chest 100 1991 1619 1636
20. C.G. Child III, and J.G. Turcotte Surgery and portal hypertension C.G. Child III The liver and portal hypertension 1964 Saunders Philadelphia 50
21. M. Tisdale Cancer cachexia Langenbecks Arch Surg 389 2004 299 305
22. D.A. Brenner, F. Buck, S.P. Feitelberg, and M. Chojkier Tumor necrosis factor alpha inhibits albumin gene expression in a murine model of cachexia J Clin Invest 85 1990 248 255
23. S. Tabibzadeh Human endometrium: an active site of cytokine production and action Endocr Rev 12 1991 272 290
24. D. Choi, H.J. Kim, and J.H. Yoon Endometrial cancer invasion depends on cancer-derived tumor necrosis factor-α and stromal derived hepatocyte growth factor Int J Cancer 124 2009 2428 2438
25. G. Stehle, H. Sinn, and A. Wunder Plasma protein (albumin) catabolism by the tumor itself - implications for tumor metabolism and the genesis of cachexia Crit Rev Oncol 26 1997 77 100
26. M. Di Domenico, A. Santoro, and C. Ricciardi Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization Cancer Biol Ther 12 2011 447 457